Is BIO or COO cheaper?

On trailing earnings, BIO is cheaper: BIO trades at a 47.11 P/E and COO at 57.53.

Which has grown faster, BIO or COO?

Over the past five years, COO grew revenue faster — BIO at a -0.84% CAGR versus COO at 9.73%.

Is BIO or COO more profitable?

BIO runs the higher net margin — BIO at 6.52% versus COO at 5.57%.

Which has been the better investment, BIO or COO?

Over the past 10-year, BIO delivered the higher annualized total return — BIO at 6.91% versus COO at 5.23%. Past performance doesn't predict future results.

Bio-Rad Laboratories, Inc. (BIO) vs The Cooper Companies, Inc. (COO)

COO leads on 9 of 14 compared metrics, though BIO is the cheaper stock.

A side-by-side comparison of Bio-Rad Laboratories, Inc. and The Cooper Companies, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 14, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

BIO

Bio-Rad Laboratories, Inc.

$7.73B

$285.94Healthcare

COO

The Cooper Companies, Inc.

$13.24B

$67.88Healthcare

Total return — BIO vs COO

growth of $100 · last 30y

BIO +1488.6%COO +4116.1%COO compounded faster

BIO COO

BIO vs COO: by the numbers

•COO is the larger company ($13.24B vs $7.73B market cap).
•BIO trades at the lower earnings multiple (47.11 vs 57.53 P/E).
•BIO converts more revenue to profit (6.52% vs 5.57% net margin).
•COO grew revenue faster over the past five years (9.73% vs -0.84% CAGR).

Which is better, BIO or COO?

Metric tally: BIO 5 · COO 9

It depends on what you're optimizing for:

ValueBIO(lower P/E)

GrowthCOO(faster 5Y revenue CAGR)

QualityCOO(higher ROIC)

Metrics side by side

Valuation

Metric	BIO	COO
P/E ratio	47.11●	57.53
Forward P/E	28.69	14.67●
P/S ratio	2.98●	3.13
P/B ratio	1.13●	1.61
EV / EBITDA	18.27	17.97
FCF yield	4.63%●	4.30%

Profitability

Metric	BIO	COO
Gross margin	51.87%	64.37%●
Operating margin	9.25%	11.77%●
Net margin	6.52%●	5.57%
ROE	2.46%	2.86%●
ROIC	2.04%	3.98%●

Growth (annualized)

Metric	BIO	COO
Revenue CAGR (5Y)	-0.84%	9.73%●
EPS CAGR (5Y)	-26.27%	-17.30%●
FCF CAGR (5Y)	-7.57%	6.61%●
Total return CAGR (5Y)	-13.82%	-6.25%●

Frequently asked

Which is better, BIO or COO?: It depends on your goal. value: BIO (lower P/E); growth: COO (faster 5Y revenue CAGR); quality: COO (higher ROIC). Across all compared metrics, COO leads 9 to 5.
Is BIO or COO cheaper?: On trailing earnings, BIO is cheaper: BIO trades at a 47.11 P/E and COO at 57.53.
Which has grown faster, BIO or COO?: Over the past five years, COO grew revenue faster — BIO at a -0.84% CAGR versus COO at 9.73%.
Is BIO or COO more profitable?: BIO runs the higher net margin — BIO at 6.52% versus COO at 5.57%.
Which has been the better investment, BIO or COO?: Over the past 10-year, BIO delivered the higher annualized total return — BIO at 6.91% versus COO at 5.23%. Past performance doesn't predict future results.

Go deeper

Full BIO analysis Full COO analysis Interactive comparison tool

Dig into the metrics

Bio-Rad Laboratories P/E ratio Cooper Companies P/E ratio Bio-Rad Laboratories dividend yield Cooper Companies dividend yield Bio-Rad Laboratories ROE Cooper Companies ROE Bio-Rad Laboratories operating margin Cooper Companies operating margin Bio-Rad Laboratories revenue growth Cooper Companies revenue growth Bio-Rad Laboratories free cash flow Cooper Companies free cash flow

Bio-Rad Laboratories & Cooper Companies appear in these rankings

Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 14, 2026.